node1	node2	edge_score	
DB09401	BCL2L1	1.0	
DB09401	MCL1	1.0	
DB09401	BCL2	1.0	
BCL2		1.0
MCL1		1.0
Adenomas, multiple colorectal, 608456 (3)	BCL2	1.0	
Adenomas, multiple colorectal, 608456 (3)	MCL1	1.0	
Neoplasm of the adrenal gland	BCL2	1.0	
Neoplasm of the adrenal gland	MCL1	1.0	
Anxiety Disorders	BCL2	1.0	
Anxiety Disorders	MCL1	1.0	
Rheumatoid arthritis	BCL2	1.0	
Rheumatoid arthritis	MCL1	1.0	
Malignant tumor of urinary bladder	BCL2	1.0	
Malignant tumor of urinary bladder	MCL1	1.0	
Brain neoplasm	BCL2	1.0	
Brain neoplasm	MCL1	1.0	
Breast-ovarian cancer, familial 1	BCL2	1.0	
Breast-ovarian cancer, familial 1	MCL1	1.0	
Burkitt lymphoma	BCL2	1.0	
Burkitt lymphoma	MCL1	1.0	
Colon cancer	BCL2	1.0	
Colon cancer	MCL1	1.0	
Malignant neoplasm of endometrium	BCL2	1.0	
Malignant neoplasm of endometrium	MCL1	1.0	
Malignant neoplasm of larynx	BCL2	1.0	
Malignant neoplasm of larynx	MCL1	1.0	
Merkel cell carcinoma	BCL2	1.0	
Merkel cell carcinoma	MCL1	1.0	
Non-small cell lung carcinoma	BCL2	1.0	
Non-small cell lung carcinoma	MCL1	1.0	
Renal cell carcinoma, nonpapillary	BCL2	1.0	
Renal cell carcinoma, nonpapillary	MCL1	1.0	
Squamous cell carcinoma	BCL2	1.0	
Squamous cell carcinoma	MCL1	1.0	
Malignant tumor of cervix	BCL2	1.0	
Malignant tumor of cervix	MCL1	1.0	
Choriocarcinoma	BCL2	1.0	
Choriocarcinoma	MCL1	1.0	
Ulcerative colitis	BCL2	1.0	
Ulcerative colitis	MCL1	1.0	
Colorectal cancer 1	BCL2	1.0	
Colorectal cancer 1	MCL1	1.0	
Colorectal Neoplasms	BCL2	1.0	
Colorectal Neoplasms	MCL1	1.0	
Verotoxigenic Escherichia coli gastrointestinal tract infection	BCL2	1.0	
Verotoxigenic Escherichia coli gastrointestinal tract infection	MCL1	1.0	
Death, Sudden, Cardiac	BCL2	1.0	
Death, Sudden, Cardiac	MCL1	1.0	
Depressive Disorder	BCL2	1.0	
Depressive Disorder	MCL1	1.0	
Diabetes Mellitus, Type 1	BCL2	1.0	
Diabetes Mellitus, Type 1	MCL1	1.0	
Glioblastoma	BCL2	1.0	
Glioblastoma	MCL1	1.0	
Glioma	BCL2	1.0	
Glioma	MCL1	1.0	
Acute type B viral hepatitis	BCL2	1.0	
Acute type B viral hepatitis	MCL1	1.0	
Histiocytosis, Langerhans-Cell	BCL2	1.0	
Histiocytosis, Langerhans-Cell	MCL1	1.0	
Hydatidiform mole, recurrent, 2	BCL2	1.0	
Hydatidiform mole, recurrent, 2	MCL1	1.0	
Leiomyoma	BCL2	1.0	
Leiomyoma	MCL1	1.0	
Leukemia, Lymphocytic, Chronic, B-Cell	BCL2	1.0	
Leukemia, Lymphocytic, Chronic, B-Cell	MCL1	1.0	
Chronic Lymphocytic Leukemia	BCL2	1.0	
Chronic Lymphocytic Leukemia	MCL1	1.0	
Acute Erythroblastic Leukemia	BCL2	1.0	
Acute Erythroblastic Leukemia	MCL1	1.0	
Acute lymphoid leukemia	BCL2	1.0	
Acute lymphoid leukemia	MCL1	1.0	
Leukemia, Lymphocytic, Acute, L1	BCL2	1.0	
Leukemia, Lymphocytic, Acute, L1	MCL1	1.0	
Acute myeloid leukemia	BCL2	1.0	
Acute myeloid leukemia	MCL1	1.0	
Myeloid leukemia	BCL2	1.0	
Myeloid leukemia	MCL1	1.0	
Chronic myeloid leukemia	BCL2	1.0	
Chronic myeloid leukemia	MCL1	1.0	
Acute promyelocytic leukemia	BCL2	1.0	
Acute promyelocytic leukemia	MCL1	1.0	
Leukemia, T-cell acute lymphoblastoid (2)	BCL2	1.0	
Leukemia, T-cell acute lymphoblastoid (2)	MCL1	1.0	
Adult T-Cell Lymphoma/Leukemia	BCL2	1.0	
Adult T-Cell Lymphoma/Leukemia	MCL1	1.0	
Leukoplakia	BCL2	1.0	
Leukoplakia	MCL1	1.0	
Neoplasm of the liver	BCL2	1.0	
Neoplasm of the liver	MCL1	1.0	
Lung Neoplasms	BCL2	1.0	
Lung Neoplasms	MCL1	1.0	
Lymphoma, Large B-Cell, Diffuse	BCL2	1.0	
Lymphoma, Large B-Cell, Diffuse	MCL1	1.0	
Lymphoma, Follicular	BCL2	1.0	
Lymphoma, Follicular	MCL1	1.0	
Non-Hodgkin lymphoma	BCL2	1.0	
Non-Hodgkin lymphoma	MCL1	1.0	
Waldenstrom macroglobulinemia	BCL2	1.0	
Waldenstrom macroglobulinemia	MCL1	1.0	
{Gastric cancer risk after H. pylori infection}, 137215 (3)	BCL2	1.0	
{Gastric cancer risk after H. pylori infection}, 137215 (3)	MCL1	1.0	
Animal Mammary Neoplasms	BCL2	1.0	
Animal Mammary Neoplasms	MCL1	1.0	
Melanoma	BCL2	1.0	
Melanoma	MCL1	1.0	
Multiple Myeloma	BCL2	1.0	
Multiple Myeloma	MCL1	1.0	
Secondary hypertriglyceridemia	BCL2	1.0	
Secondary hypertriglyceridemia	MCL1	1.0	
Obesity	BCL2	1.0	
Obesity	MCL1	1.0	
Plasmacytoma	BCL2	1.0	
Plasmacytoma	MCL1	1.0	
Pneumonia	BCL2	1.0	
Pneumonia	MCL1	1.0	
Precancerous Conditions	BCL2	1.0	
Precancerous Conditions	MCL1	1.0	
Retinoblastoma	BCL2	1.0	
Retinoblastoma	MCL1	1.0	
Rhabdomyosarcoma alveolar	BCL2	1.0	
Rhabdomyosarcoma alveolar	MCL1	1.0	
Septicemia	BCL2	1.0	
Septicemia	MCL1	1.0	
Skin lesion	BCL2	1.0	
Skin lesion	MCL1	1.0	
Stomach Neoplasms	BCL2	1.0	
Stomach Neoplasms	MCL1	1.0	
Tuberculosis	BCL2	1.0	
Tuberculosis	MCL1	1.0	
Uterine leiomyoma	BCL2	1.0	
Uterine leiomyoma	MCL1	1.0	
Virus Diseases	BCL2	1.0	
Virus Diseases	MCL1	1.0	
B-cell lymphoma	BCL2	1.0	
B-cell lymphoma	MCL1	1.0	
Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	BCL2	1.0	
Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	MCL1	1.0	
Lymphoma, Large-Cell, Follicular	BCL2	1.0	
Lymphoma, Large-Cell, Follicular	MCL1	1.0	
Cutaneous T-cell lymphoma	BCL2	1.0	
Cutaneous T-cell lymphoma	MCL1	1.0	
Peripheral T-Cell Lymphoma	BCL2	1.0	
Peripheral T-Cell Lymphoma	MCL1	1.0	
Acute leukemia	BCL2	1.0	
Acute leukemia	MCL1	1.0	
Small cell lung cancer	BCL2	1.0	
Small cell lung cancer	MCL1	1.0	
Cancer of mouth	BCL2	1.0	
Cancer of mouth	MCL1	1.0	
Malignant neoplasm of oropharynx	BCL2	1.0	
Malignant neoplasm of oropharynx	MCL1	1.0	
Uterine Corpus Cancer	BCL2	1.0	
Uterine Corpus Cancer	MCL1	1.0	
Tumor Progression	BCL2	1.0	
Tumor Progression	MCL1	1.0	
Anaplastic large cell lymphoma, ALK negative	BCL2	1.0	
Anaplastic large cell lymphoma, ALK negative	MCL1	1.0	
Cholangiocarcinoma	BCL2	1.0	
Cholangiocarcinoma	MCL1	1.0	
Lip and Oral Cavity Carcinoma	BCL2	1.0	
Lip and Oral Cavity Carcinoma	MCL1	1.0	
Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease	BCL2	1.0	
Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease	MCL1	1.0	
Combined Hepatocellular Carcinoma and Cholangiocarcinoma	BCL2	1.0	
Combined Hepatocellular Carcinoma and Cholangiocarcinoma	MCL1	1.0	
Pancreatic Carcinoma	BCL2	1.0	
Pancreatic Carcinoma	MCL1	1.0	
Malignant neoplasm of lung	BCL2	1.0	
Malignant neoplasm of lung	MCL1	1.0	
Neoplasm, Residual	BCL2	1.0	
Neoplasm, Residual	MCL1	1.0	
Sepsis	BCL2	1.0	
Sepsis	MCL1	1.0	
Gastric Adenocarcinoma	BCL2	1.0	
Gastric Adenocarcinoma	MCL1	1.0	
Esophageal Squamous Cell Carcinoma	BCL2	1.0	
Esophageal Squamous Cell Carcinoma	MCL1	1.0	
Solid tumour	BCL2	1.0	
Solid tumour	MCL1	1.0	
Carcinoma of cervix	BCL2	1.0	
Carcinoma of cervix	MCL1	1.0	
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	BCL2	1.0	
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	MCL1	1.0	
Adenocarcinoma of colon	BCL2	1.0	
Adenocarcinoma of colon	MCL1	1.0	
Hepatic cancer metastatic	BCL2	1.0	
Hepatic cancer metastatic	MCL1	1.0	
Malignant mesothelioma	BCL2	1.0	
Malignant mesothelioma	MCL1	1.0	
Malignant neoplasm of pancreas	BCL2	1.0	
Malignant neoplasm of pancreas	MCL1	1.0	
Malignant tumor of prostate	BCL2	1.0	
Malignant tumor of prostate	MCL1	1.0	
Hematological neoplasm	BCL2	1.0	
Hematological neoplasm	MCL1	1.0	
Follicular neoplasm	BCL2	1.0	
Follicular neoplasm	MCL1	1.0	
Endometrial carcinoma	BCL2	1.0	
Endometrial carcinoma	MCL1	1.0	
Squamous cell carcinoma of the skin	BCL2	1.0	
Squamous cell carcinoma of the skin	MCL1	1.0	
Malignant Glioma	BCL2	1.0	
Malignant Glioma	MCL1	1.0	
Osteosarcoma	BCL2	1.0	
Osteosarcoma	MCL1	1.0	
Laryngeal carcinoma	BCL2	1.0	
Laryngeal carcinoma	MCL1	1.0	
Carcinogenesis	BCL2	1.0	
Carcinogenesis	MCL1	1.0	
Leukemogenesis	BCL2	1.0	
Leukemogenesis	MCL1	1.0	
Prostate carcinoma	BCL2	1.0	
Prostate carcinoma	MCL1	1.0	
Ovarian epithelial cancer	BCL2	1.0	
Ovarian epithelial cancer	MCL1	1.0	
Progressive Neoplastic Disease	BCL2	1.0	
Progressive Neoplastic Disease	MCL1	1.0	
Breast carcinoma	BCL2	1.0	
Breast carcinoma	MCL1	1.0	
Lung cancer	BCL2	1.0	
Lung cancer	MCL1	1.0	
Carcinoma of colon	BCL2	1.0	
Carcinoma of colon	MCL1	1.0	
Stomach cancer	BCL2	1.0	
Stomach cancer	MCL1	1.0	
Bladder carcinoma	BCL2	1.0	
Bladder carcinoma	MCL1	1.0	
Neuroblastoma	BCL2	1.0	
Neuroblastoma	MCL1	1.0	
Pleural Mesothelioma	BCL2	1.0	
Pleural Mesothelioma	MCL1	1.0	
Gestational trophoblastic disease	BCL2	1.0	
Gestational trophoblastic disease	MCL1	1.0	
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	BCL2	1.0	
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	MCL1	1.0	
Endometrial adenocarcinoma	BCL2	1.0	
Endometrial adenocarcinoma	MCL1	1.0	
Squamous cell carcinoma of the head and neck	BCL2	1.0	
Squamous cell carcinoma of the head and neck	MCL1	1.0	
Sarcoma, Ewing	BCL2	1.0	
Sarcoma, Ewing	MCL1	1.0	
B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	BCL2	1.0	
B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	MCL1	1.0	
Cancer Cell Growth	BCL2	1.0	
Cancer Cell Growth	MCL1	1.0	
Xenograft Model	BCL2	1.0	
Xenograft Model	MCL1	1.0	
Colorectal cancer	BCL2	1.0	
Colorectal cancer	MCL1	1.0	
Non-Malignant Ascites Adverse Event	BCL2	1.0	
Non-Malignant Ascites Adverse Event	MCL1	1.0	
Glioblastoma multiforme	BCL2	1.0	
Glioblastoma multiforme	MCL1	1.0	
Non-Neoplastic Disorder	BCL2	1.0	
Non-Neoplastic Disorder	MCL1	1.0	
Severe Sepsis	BCL2	1.0	
Severe Sepsis	MCL1	1.0	
Multicystic renal dysplasia, bilateral	BCL2	1.0	
Multicystic renal dysplasia, bilateral	MCL1	1.0	
Glucocorticoid resistance, generalized	BCL2	1.0	
Glucocorticoid resistance, generalized	MCL1	1.0	
Coronary Artery Disease	BCL2	1.0	
Coronary Artery Disease	MCL1	1.0	
T-cell acute lymphoblastic leukemias	BCL2	1.0	
T-cell acute lymphoblastic leukemias	MCL1	1.0	
Precursor Cell Lymphoblastic Leukemia-Lymphoma	BCL2	1.0	
Precursor Cell Lymphoblastic Leukemia-Lymphoma	MCL1	1.0	
Leukemia, B-Cell	BCL2	1.0	
Leukemia, B-Cell	MCL1	1.0	
Hepatocellular carcinoma	BCL2	1.0	
Hepatocellular carcinoma	MCL1	1.0	
Oropharyngeal Carcinoma	BCL2	1.0	
Oropharyngeal Carcinoma	MCL1	1.0	
Secondary malignant neoplasm of pancreas	BCL2	1.0	
Secondary malignant neoplasm of pancreas	MCL1	1.0	
Hydatidiform mole, recurrent, 1, 231090 (3)	BCL2	1.0	
Hydatidiform mole, recurrent, 1, 231090 (3)	MCL1	1.0	
Progressive cGVHD	BCL2	1.0	
Progressive cGVHD	MCL1	1.0	
Triple Negative Breast Neoplasms	BCL2	1.0	
Triple Negative Breast Neoplasms	MCL1	1.0	
Experimental Organism Basal Cell Carcinoma	BCL2	1.0	
Experimental Organism Basal Cell Carcinoma	MCL1	1.0	
Hypercapnia	BCL2	1.0	
Oculopharyngeal muscular dystrophy	BCL2	1.0	
Cutaneous lymphoma	BCL2	1.0	
Plasmablastic lymphoma	BCL2	1.0	
Lymphoid hyperplasia	BCL2	1.0	
Malignant neoplasm of adrenal cortex	BCL2	1.0	
Oropharynx (excludes nasopharynx)	BCL2	1.0	
Bulimia	MCL1	1.0	
Cervical dysplasia	BCL2	1.0	
Cryoglobulinemia	BCL2	1.0	
Seborrheic keratosis	BCL2	1.0	
Gallbladder adenocarcinoma	BCL2	1.0	
Fowlpox	BCL2	1.0	
Chromosomal translocation	BCL2	1.0	
Carcinoma, Signet Ring Cell	BCL2	1.0	
Squamous Cell Neoplasms	BCL2	1.0	
gastritis h pylori	BCL2	1.0	
Generalized anxiety disorder	BCL2	1.0	
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	BCL2	1.0	
Monocytosis	BCL2	1.0	
Chronic leukemia	BCL2	1.0	
Normal pressure hydrocephalus	BCL2	1.0	
Circumscribed scleroderma	BCL2	1.0	
Superinfection	BCL2	1.0	
Uterine leiomyosarcoma	BCL2	1.0	
Complete hydatidiform mole	BCL2	1.0	
Aggressive Non-Hodgkin Lymphoma	BCL2	1.0	
Cervix Diseases	BCL2	1.0	
Fatal infectious mononucleosis	BCL2	1.0	
Lichen planus pemphigoides	BCL2	1.0	
Meningitis, Pneumococcal	BCL2	1.0	
Comedone	BCL2	1.0	
Prostate cancer recurrent	BCL2	1.0	
Hypervolemia	BCL2	1.0	
Dermatitis Herpetiformis	BCL2	1.0	
Complete trisomy 18 syndrome	BCL2	1.0	
AIDS related complex	BCL2	1.0	
Condylomata Acuminata	BCL2	1.0	
Folic Acid Deficiency	BCL2	1.0	
Odontogenic neoplasm	BCL2	1.0	
Mediastinal (Thymic) Large B-Cell Lymphoma	BCL2	1.0	
Ovarian hyperstimulation syndrome	MCL1	1.0	
Lymphoma, AIDS-Related	BCL2	1.0	
Lymphosarcoma	BCL2	1.0	
Diffuse Astrocytoma	BCL2	1.0	
Prolymphocytic Leukemia	BCL2	1.0	
Plague	MCL1	1.0	
Prostatic Diseases	BCL2	1.0	
Small Lymphocytic Lymphoma	BCL2	1.0	
Arteriovenous fistula	BCL2	1.0	
Bronchogenic Carcinoma	BCL2	1.0	
Rabies (disorder)	BCL2	1.0	
Neoplasm of the tongue	BCL2	1.0	
Mixed cryoglobulinemia	BCL2	1.0	
Thrombotic Microangiopathies	BCL2	1.0	
Precursor cell lymphoblastic lymphoma	BCL2	1.0	
Primary central nervous system lymphoma	BCL2	1.0	
Cervical intraepithelial neoplasia grade 1	BCL2	1.0	
Primary Carcinoma	BCL2	1.0	
Yolk Sac Tumor	MCL1	1.0	
Fuchs' Endothelial Dystrophy	BCL2	1.0	
Reticulosarcoma	BCL2	1.0	
Thromboangiitis Obliterans	BCL2	1.0	
Varicose Ulcer	BCL2	1.0	
Learning Disorders	BCL2	1.0	
Li-Fraumeni syndrome	BCL2	1.0	
Trisomy 12	BCL2	1.0	
Neck Neoplasms	BCL2	1.0	
Neoplasm of the gallbladder	BCL2	1.0	
Pleuritis	BCL2	1.0	
Ganglioneuroblastoma	BCL2	1.0	
Cervical intraepithelial neoplasia grade 2	BCL2	1.0	
Splenic Marginal Zone B-Cell Lymphoma	BCL2	1.0	
Atypical teratoid/rhabdoid tumor	BCL2	1.0	
Severe congenital neutropenia	BCL2	1.0	
Malignant neoplasm of female breast	BCL2	1.0	
Squamous intraepithelial lesion	BCL2	1.0	
Urticaria Pigmentosa	BCL2	1.0	
Cervical Adenocarcinoma	BCL2	1.0	
Carcinoma in situ of uterine cervix	BCL2	1.0	
Drug Resistant Epilepsy	BCL2	1.0	
Gorlin syndrome	BCL2	1.0	
Female Breast Carcinoma	BCL2	1.0	
Endometrial Hyperplasia	BCL2	1.0	
Acute myelomonocytic leukemia	MCL1	1.0	
Tongue Carcinoma	BCL2	1.0	
Abnormality of the pleura	BCL2	1.0	
Refractory anaemia with excess blasts	BCL2	1.0	
Marfan syndrome	MCL1	1.0	
Carcinoma, Neuroendocrine	BCL2	1.0	
Memory Disorders	BCL2	1.0	
Necrosis	BCL2	1.0	
Multiple endocrine neoplasia, type 4	BCL2	1.0	
Sicca Syndrome	BCL2	1.0	
Endometriosis of uterus	BCL2	1.0	
Aicardi Goutieres syndrome 1	BCL2	1.0	
Diabetic Cardiomyopathies	BCL2	1.0	
Autoimmune lymphoproliferative syndrome, type 2	BCL2	1.0	
Photoreceptor degeneration	BCL2	1.0	
Mastocytosis	BCL2	1.0	
Medullary carcinoma	BCL2	1.0	
Malignant Fibrous Histiocytoma	BCL2	1.0	
Angioimmunoblastic Lymphadenopathy	BCL2	1.0	
Oropharyngeal squamous cell carcinoma	BCL2	1.0	
Neoplasm of the parathyroid gland	BCL2	1.0	
cancer recurrence	BCL2	1.0	
Memory Loss	BCL2	1.0	
Adenomatous polyp of colon	BCL2	1.0	
Ovarian adenocarcinoma	BCL2	1.0	
Infiltrating Cervical Carcinoma	BCL2	1.0	
Other specified disorders of breast	BCL2	1.0	
Childhood Leukemia	BCL2	1.0	
Diamond-Blackfan anemia	BCL2	1.0	
Persistent infection	BCL2	1.0	
Refractory cancer	BCL2	1.0	
Chronic lung disease	BCL2	1.0	
Bipolar I disorder	BCL2	1.0	
Ameloblastoma	BCL2	1.0	
Atypical nevus	BCL2	1.0	
Fibroadenoma of the breast	BCL2	1.0	
Renal dysplasia	BCL2	1.0	
Hypoxia-Ischemia, Brain	BCL2	1.0	
Hepatosplenic schistosomiasis	BCL2	1.0	
Microalbuminuria	BCL2	1.0	
Neoplasms, Intracranial	BCL2	1.0	
Malformation of cortical development	BCL2	1.0	
Lymphocytosis	BCL2	1.0	
Shock, Septic	BCL2	1.0	
Mitochondrial DNA depletion syndrome, hepatocerebral form	BCL2	1.0	
Nephronophthisis	BCL2	1.0	
Nasopharyngeal cancer recurrent	BCL2	1.0	
Acute Lung Injury	BCL2	1.0	
{Pemphigoid, susceptibility to} (2)	BCL2	1.0	
Miller Dieker syndrome	BCL2	1.0	
Viral hepatitis	BCL2	1.0	
Embryonal neoplasm	BCL2	1.0	
Pathologic Neovascularization	BCL2	1.0	
Acute monocytic leukemia	MCL1	1.0	
Oral leukoplakia	BCL2	1.0	
Postoperative Complications	BCL2	1.0	
Pleural Effusion, Malignant	BCL2	1.0	
Adenovirus Infections	BCL2	1.0	
Pulmonary edema	BCL2	1.0	
Chronic gastritis	BCL2	1.0	
Brain Infarction	BCL2	1.0	
Salivary gland neoplasm	BCL2	1.0	
Amyotrophic Lateral Sclerosis, Sporadic	BCL2	1.0	
Scar conditions and fibrosis of skin	BCL2	1.0	
Metaplasia	BCL2	1.0	
Benign melanocytic nevus	BCL2	1.0	
Rash and Dermatitis Adverse Event Associated with Chemoradiation	BCL2	1.0	
Hormone refractory prostate cancer	BCL2	1.0	
Chlamydia Infections	BCL2	1.0	
granulosa cell tumor	BCL2	1.0	
Undifferentiated carcinoma	BCL2	1.0	
Lichen Planus, Oral	BCL2	1.0	
Infarction, Middle Cerebral Artery	BCL2	1.0	
Renal ischaemia	BCL2	1.0	
CNS infection	BCL2	1.0	
Nasopharyngeal Neoplasms	BCL2	1.0	
Mucinous Adenocarcinoma	BCL2	1.0	
Cholera	BCL2	1.0	
Pterygium	BCL2	1.0	
Soft Tissue Neoplasms	BCL2	1.0	
Herpes NOS	BCL2	1.0	
Carcinoid tumor no ICD-O subtype	BCL2	1.0	
Necrotizing Enterocolitis	BCL2	1.0	
Thyroid adenoma	BCL2	1.0	
Adrenocortical adenoma	BCL2	1.0	
Contact Dermatitis	BCL2	1.0	
Oral Cavity Carcinoma	BCL2	1.0	
Adult Acute Myeloblastic Leukemia	BCL2	1.0	
Thyroid associated opthalmopathies	BCL2	1.0	
High-Grade Prostatic Intraepithelial Neoplasia	BCL2	1.0	
Actinic keratosis	BCL2	1.0	
Neuromuscular Diseases	BCL2	1.0	
Skin nodule	BCL2	1.0	
Lymphedema, primary, with myelodysplasia	BCL2	1.0	
Adenocarcinoma, Clear Cell	BCL2	1.0	
Inflammatory Breast Carcinoma	BCL2	1.0	
Cerebral palsy, spastic quadriplegic, 3	BCL2	1.0	
Skin carcinoma	BCL2	1.0	
Oxyphilic Adenoma	BCL2	1.0	
Endotoxemia	BCL2	1.0	
Vesicular Stomatitis	BCL2	1.0	
Multicystic kidney dysplasia	BCL2	1.0	
Interstitial fibrosis	BCL2	1.0	
Advanced cancer	BCL2	1.0	
Melanoma, B16	BCL2	1.0	
Liver Cirrhosis, Alcoholic	BCL2	1.0	
Adult Acute Lymphocytic Leukemia	BCL2	1.0	
Neoplasm of the rectum	BCL2	1.0	
High grade serous carcinoma	BCL2	1.0	
Rhabdoid Tumor of the Kidney	BCL2	1.0	
Posttraumatic stress disorder	BCL2	1.0	
precancerous lesions	BCL2	1.0	
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	BCL2	1.0	
Middle Cerebral Artery Occlusion	BCL2	1.0	
Teratoma	MCL1	1.0	
Clear-cell metastatic renal cell carcinoma	BCL2	1.0	
Mixed Salivary Gland Tumor	BCL2	1.0	
Glomerulosclerosis, Focal Segmental	BCL2	1.0	
tumor vasculature	BCL2	1.0	
Hairy Cell Leukemia	BCL2	1.0	
Skin Carcinogenesis	BCL2	1.0	
Dermatitis, Allergic Contact	BCL2	1.0	
CNS disorder	BCL2	1.0	
Adrenal insufficiency	BCL2	1.0	
early pregnancy	BCL2	1.0	
Chronic atrophic gastritis	BCL2	1.0	
Gastric ulcer	BCL2	1.0	
Meningitis	BCL2	1.0	
Breast adenocarcinoma	MCL1	1.0	
Mammary Ductal Carcinoma	BCL2	1.0	
Knee osteoarthritis	BCL2	1.0	
Xeroderma pigmentosum, group E	BCL2	1.0	
Squamous cell carcinoma of tongue	BCL2	1.0	
Bilateral cataracts (disorder)	BCL2	1.0	
Primary Effusion Lymphoma	BCL2	1.0	
Liposarcoma	BCL2	1.0	
Peptic ulcer	BCL2	1.0	
Carcinoma, Endometrioid	BCL2	1.0	
Lymphadenopathy	BCL2	1.0	
Impotence	BCL2	1.0	
Common variable immunodeficiency 2	BCL2	1.0	
Abnormality of the lymph nodes	BCL2	1.0	
Transitional cell carcinoma of the bladder	BCL2	1.0	
Lewy Body Disease	BCL2	1.0	
Intraepithelial Neoplasia	BCL2	1.0	
Metastatic malignant neoplasm to brain	BCL2	1.0	
Thyroiditis	BCL2	1.0	
Laryngeal Squamous Cell Carcinoma	BCL2	1.0	
 {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	BCL2	1.0	
Acute hepatic failure	BCL2	1.0	
Anaplastic Oligodendroglioma	BCL2	1.0	
Basal cell carcinoma	MCL1	1.0	
Leiomyosarcoma	BCL2	1.0	
Liver Neoplasms, Experimental	BCL2	1.0	
Motor Neuron Disease	BCL2	1.0	
Pleural effusion	BCL2	1.0	
Anaplastic astrocytoma	BCL2	1.0	
Testicular Neoplasms	BCL2	1.0	
Adrenoleukodystrophy	BCL2	1.0	
Mild cognitive impairment	BCL2	1.0	
Mammary Tumorigenesis	BCL2	1.0	
Disorder characterized by eosinophilia	BCL2	1.0	
Hematological Disease	BCL2	1.0	
Hyperplasia	BCL2	1.0	
Eosinophilic disorder	BCL2	1.0	
Neoplastic Cell Transformation	BCL2	1.0	
Neurodegeneration with brain iron accumulation	BCL2	1.0	
Chronic liver disease	BCL2	1.0	
Intestinal Neoplasms	BCL2	1.0	
Sporadic Breast Carcinoma	BCL2	1.0	
Barrett Esophagus	MCL1	1.0	
invasive cancer	BCL2	1.0	
Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation	BCL2	1.0	
androgen independent prostate cancer	BCL2	1.0	
Hemangioma	BCL2	1.0	
Glomerulopathy	BCL2	1.0	
Adenocarcinoma of prostate	BCL2	1.0	
Disseminated Malignant Neoplasm	BCL2	1.0	
Acquired Immunodeficiency Syndrome	BCL2	1.0	
Myeloproliferative disorder (2)	BCL2	1.0	
Encephalitis	BCL2	1.0	
Lymphatic Metastasis	BCL2	1.0	
Malignant neoplasm of gallbladder	BCL2	1.0	
Hematopoietic Neoplasms	BCL2	1.0	
Tumor necrosis	BCL2	1.0	
Uterine Cervical Neoplasms	BCL2	1.0	
Amyotrophic lateral sclerosis type 1	BCL2	1.0	
Aplastic anemia	BCL2	1.0	
Borderline Personality Disorder	BCL2	1.0	
Nevus	BCL2	1.0	
Eosinophilia	BCL2	1.0	
Thymoma	BCL2	1.0	
Keloid	BCL2	1.0	
Synovial sarcoma	BCL2	1.0	
Trisomy	BCL2	1.0	
Embryonal Carcinoma	MCL1	1.0	
Synovial Cyst	BCL2	1.0	
Tumor Initiation	BCL2	1.0	
Carcinoid tumor	BCL2	1.0	
Vasculitis	BCL2	1.0	
Cyst	MCL1	1.0	
Kaposi's sarcoma	BCL2	1.0	
Melanocytic nevus	BCL2	1.0	
Status epilepticus	BCL2	1.0	
Spinal muscular atrophy with congenital bone fractures 2	BCL2	1.0	
Adenocarcinoma of the large intestine	BCL2	1.0	
Well Differentiated Oligodendroglioma	BCL2	1.0	
Dilated cardiomyopathy 1A	BCL2	1.0	
Epilepsy, Temporal Lobe	BCL2	1.0	
Squamous cell carcinoma of lung	BCL2	1.0	
Gallbladder Carcinoma	BCL2	1.0	
Primary cutaneous marginal zone B-cell lymphoma	BCL2	1.0	
Myocardial Reperfusion Injury	BCL2	1.0	
Papilloma	BCL2	1.0	
Chronic hepatitis	BCL2	1.0	
Medullary thyroid carcinoma	BCL2	1.0	
Skeletal dysplasia	BCL2	1.0	
Intraocular melanoma	BCL2	1.0	
Mammary Neoplasms, Experimental	BCL2	1.0	
Hypercholesterolemia, autosomal dominant, type B	BCL2	1.0	
Cervical intraepithelial neoplasia (Cervical dysplasia)	BCL2	1.0	
Benign neoplasm of other endocrine glands	BCL2	1.0	
Meningioma, benign, no ICD-O subtype	BCL2	1.0	
Tuberculosis, Pulmonary	MCL1	1.0	
Epstein-Barr Virus Infections	BCL2	1.0	
Hepatoblastoma	BCL2	1.0	
Blast Phase	BCL2	1.0	
Skin cancer	BCL2	1.0	
Chondrosarcoma	BCL2	1.0	
Testicular seminoma	BCL2	1.0	
Anaplastic thyroid carcinoma	BCL2	1.0	
Ductal Carcinoma	BCL2	1.0	
Plaque, Atherosclerotic	BCL2	1.0	
Neoplasm of the oral cavity	MCL1	1.0	
Primary pulmonary hypertension	BCL2	1.0	
Malignant hyperthermia susceptibility type 5	BCL2	1.0	
Anaplasia	BCL2	1.0	
Invasive Ductal Breast Carcinoma	BCL2	1.0	
Carcinoma, Papillary	BCL2	1.0	
Disease Progression	BCL2	1.0	
Abnormality of temperature regulation	BCL2	1.0	
Lymphoproliferative disorder	BCL2	1.0	
Nasal polyposis	BCL2	1.0	
Ovarian Diseases	BCL2	1.0	
Bronchopulmonary Dysplasia	BCL2	1.0	
Gastritis	BCL2	1.0	
Dermal atrophy	BCL2	1.0	
Acute myocardial infarction	BCL2	1.0	
Mitral stenosis	BCL2	1.0	
Hypergranular promyelocytic leukemia	BCL2	1.0	
Myeloproliferative Disorders	BCL2	1.0	
Cerebral Hemorrhage	BCL2	1.0	
Malignant gastrointestinal tract tumors	BCL2	1.0	
Lymphoid leukemia	BCL2	1.0	
Germ cell neoplasia	BCL2	1.0	
Neuroendocrine neoplasm	BCL2	1.0	
Fibrosarcoma	BCL2	1.0	
Recurrent bacterial infection	BCL2	1.0	
Neutropenia	BCL2	1.0	
Adenoma of large intestine	BCL2	1.0	
Microphthalmia syndromic 6	BCL2	1.0	
Hyperkeratosis	BCL2	1.0	
Pheochromocytoma	BCL2	1.0	
Azoospermia	BCL2	1.0	
Primary biliary cirrhosis	BCL2	1.0	
Cutaneous malignant melanoma 3	BCL2	1.0	
Narcolepsy	MCL1	1.0	
Glomerulonephritis, Membranous	BCL2	1.0	
Endometrial Neoplasms	BCL2	1.0	
Acute kidney injury	BCL2	1.0	
Cerebral ischemia	BCL2	1.0	
Neoplasm Recurrence, Local	BCL2	1.0	
Epithelioma	BCL2	1.0	
Clubfoot	BCL2	1.0	
polyps	BCL2	1.0	
Splenomegaly	BCL2	1.0	
Rectal Carcinoma	BCL2	1.0	
Retinal degeneration	BCL2	1.0	
Noninfiltrating Intraductal Carcinoma	BCL2	1.0	
Ischaemic cerebral infarction	BCL2	1.0	
Helicobacter pylori infection	BCL2	1.0	
Adenocarcinoma Of Esophagus	BCL2	1.0	
Leukopenia	BCL2	1.0	
Dementia familial British	BCL2	1.0	
T-cell lymphoma	BCL2	1.0	
Male infertility	BCL2	1.0	
Reperfusion Injury	BCL2	1.0	
Lupus Vulgaris	BCL2	1.0	
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	BCL2	1.0	
Pulmonary arterial hypertension	BCL2	1.0	
Discoid lupus erythematosus	BCL2	1.0	
Huntington's chorea	BCL2	1.0	
Pancreatic adenocarcinoma	BCL2	1.0	
Recurrent tumor	BCL2	1.0	
Acute Coronary Syndrome	BCL2	1.0	
Pituitary Neoplasms	BCL2	1.0	
Mood Disorders	BCL2	1.0	
Head and Neck Neoplasms	BCL2	1.0	
Pulmonary hypertension, neonatal, susceptibility to	BCL2	1.0	
Metastatic melanoma	BCL2	1.0	
Hypoxia	BCL2	1.0	
Hydrops, lactic acidosis, and sideroblastic anemia	BCL2	1.0	
Gastrointestinal stromal tumor	BCL2	1.0	
Carcinoma breast stage IV	BCL2	1.0	
Chronic kidney disease	BCL2	1.0	
Abnormality of fluid regulation	BCL2	1.0	
Abnormality of the spleen	BCL2	1.0	
Wilms Tumor	BCL2	1.0	
Renal neoplasm	BCL2	1.0	
Renal Insufficiency, Chronic	BCL2	1.0	
Fatigue	BCL2	1.0	
Clear cell renal cell carcinoma	BCL2	1.0	
Invasive breast carcinoma	BCL2	1.0	
Graves Disease	BCL2	1.0	
Thyroid Diseases	BCL2	1.0	
Hepatitis	BCL2	1.0	
Pulmonary Disease, Chronic Obstructive	BCL2	1.0	
Hereditary pancreatitis	BCL2	1.0	
Intrauterine growth retardation	BCL2	1.0	
Mesothelioma, malignant	BCL2	1.0	
Heart Diseases	MCL1	1.0	
Urothelial Carcinoma	BCL2	1.0	
{Systemic lupus erythematosus, susceptibility to, 8} (2)	BCL2	1.0	
Disorders of Intracellular Cobalamin Metabolism	BCL2	1.0	
Familial adenomatous polyposis 1	BCL2	1.0	
Myelodysplastic syndrome	BCL2	1.0	
Malignant neoplasm of kidney	BCL2	1.0	
Cancer of the lower GI tract	BCL2	1.0	
Unipolar Depression	BCL2	1.0	
Behcet Syndrome	BCL2	1.0	
Hodgkin Disease	BCL2	1.0	
Brain Ischemia	BCL2	1.0	
Hepatic fibrosis	BCL2	1.0	
Benign Prostatic Hyperplasia	BCL2	1.0	
Abnormality of the lymphatic system	BCL2	1.0	
Cancer of Head and Neck	BCL2	1.0	
Retinopathy	BCL2	1.0	
Celiac Disease	BCL2	1.0	
Neoplasm of the skin	BCL2	1.0	
Tumor Angiogenesis	BCL2	1.0	
Myopathy, scapulohumeroperoneal	BCL2	1.0	
Cystic Fibrosis	BCL2	1.0	
Papillary thyroid carcinoma	BCL2	1.0	
Meningioma	BCL2	1.0	
Thyroid cancer, nonmedullary, 4	BCL2	1.0	
Hepatitis C, Chronic	BCL2	1.0	
Hyperglycemia	BCL2	1.0	
Glaucoma, Angle-Closure	BCL2	1.0	
Visceromegaly	BCL2	1.0	
Urinary Bladder Neoplasms	BCL2	1.0	
Hepatocarcinogenesis	MCL1	1.0	
Eczema	BCL2	1.0	
Down Syndrome	BCL2	1.0	
Polycystic Ovary Syndrome	BCL2	1.0	
Dementia	BCL2	1.0	
Acute myocardial ischemia	BCL2	1.0	
Thyroid Neoplasms	BCL2	1.0	
Major depressive disorder	BCL2	1.0	
Abnormality of abdomen morphology	BCL2	1.0	
Herpes Simplex Infections	BCL2	1.0	
Localized skin lesion	BCL2	1.0	
Congenital chromosomal disease	BCL2	1.0	
Malaria	BCL2	1.0	
Medulloblastoma	BCL2	1.0	
Severe combined immunodeficiency due to ADA deficiency	BCL2	1.0	
{Unipolar depression, susceptibility to}, 608516 (3)	MCL1	1.0	
Dermatitis, Atopic	BCL2	1.0	
Pancreatic Ductal Adenocarcinoma	BCL2	1.0	
Immunodeficiency due to defect in CD3-gamma	BCL2	1.0	
Constitutional symptom	BCL2	1.0	
Scleroderma	BCL2	1.0	
Neoplasm by anatomical site	BCL2	1.0	
Increased inflammatory response	BCL2	1.0	
Abnormal inflammatory response	BCL2	1.0	
Abnormality of the intestine	BCL2	1.0	
Esophageal carcinoma	BCL2	1.0	
Liver Diseases	BCL2	1.0	
Secondary malignant neoplasm of lung	BCL2	1.0	
Diabetic Nephropathies	BCL2	1.0	
Anemia	BCL2	1.0	
Scoliosis	BCL2	1.0	
Osteoporosis	BCL2	1.0	
Neoplasms	BCL2	1.0	
Ischemia	BCL2	1.0	
IgA nephropathy, susceptibility to, 3	BCL2	1.0	
Malignant tumor of esophagus	BCL2	1.0	
Abnormality of lung morphology	BCL2	1.0	
Thyroid carcinoma	BCL2	1.0	
Nasopharyngeal carcinoma, susceptibility to, 3	BCL2	1.0	
Epilepsy	BCL2	1.0	
Astrocytoma	BCL2	1.0	
EMG: myopathic abnormalities	BCL2	1.0	
Colitis, Ulcerative	BCL2	1.0	
Esophageal Neoplasms	BCL2	1.0	
Cataract, autosomal recessive congenital 5	BCL2	1.0	
Neurodegenerative Diseases	BCL2	1.0	
Hepatitis C	BCL2	1.0	
Endometriosis	BCL2	1.0	
Muscle weakness	BCL2	1.0	
